Stryker Corp (SYK)
328.37
+1.74
(+0.53%)
USD |
NYSE |
May 03, 16:00
328.37
0.00 (0.00%)
After-Hours: 20:00
Stryker Research and Development Expense (Quarterly): 368.00M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 368.00M |
| December 31, 2023 | 350.00M |
| September 30, 2023 | 353.00M |
| June 30, 2023 | 346.00M |
| March 31, 2023 | 339.00M |
| December 31, 2022 | 326.00M |
| September 30, 2022 | 364.00M |
| June 30, 2022 | 351.00M |
| March 31, 2022 | 413.00M |
| December 31, 2021 | 331.00M |
| September 30, 2021 | 306.00M |
| June 30, 2021 | 310.00M |
| March 31, 2021 | 288.00M |
| December 31, 2020 | 255.00M |
| September 30, 2020 | 242.00M |
| June 30, 2020 | 233.00M |
| March 31, 2020 | 254.00M |
| December 31, 2019 | 254.00M |
| September 30, 2019 | 246.00M |
| June 30, 2019 | 246.00M |
| March 31, 2019 | 225.00M |
| December 31, 2018 | 221.00M |
| September 30, 2018 | 221.00M |
| June 30, 2018 | 216.00M |
| March 31, 2018 | 204.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 205.00M |
| September 30, 2017 | 198.00M |
| June 30, 2017 | 192.00M |
| March 31, 2017 | 192.00M |
| December 31, 2016 | 189.00M |
| September 30, 2016 | 184.00M |
| June 30, 2016 | 183.00M |
| March 31, 2016 | 159.00M |
| December 31, 2015 | 164.00M |
| September 30, 2015 | 155.00M |
| June 30, 2015 | 154.00M |
| March 31, 2015 | 152.00M |
| December 31, 2014 | 153.00M |
| September 30, 2014 | 153.00M |
| June 30, 2014 | 158.00M |
| March 31, 2014 | 150.00M |
| December 31, 2013 | 139.00M |
| September 30, 2013 | 136.00M |
| June 30, 2013 | 132.00M |
| March 31, 2013 | 129.00M |
| December 31, 2012 | 129.00M |
| September 30, 2012 | 114.00M |
| June 30, 2012 | 116.00M |
| March 31, 2012 | 112.00M |
| December 31, 2011 | 115.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
233.00M
Minimum
Jun 2020
413.00M
Maximum
Mar 2022
308.75M
Average
318.00M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Haemonetics Corp | 13.26M |
| Abbott Laboratories | 684.00M |
| Zimmer Biomet Holdings Inc | 107.90M |
| ResMed Inc | 77.07M |